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A method of synthesizing a heteroleptic, multiple metal
containing metallocyclic catalyst, particularly Suited for
asymmetric catalysis, comprising combining a plurality of
plural functional group-containing, monodentate ligands of
complementary chirality, said plural functional groups being
tethered to each other by tethers in the presence of a scaffold
structural metal Ms orderivative thereof, wherein at least one

functional group on each ligand combines to ligate M to form
a bidentate, M. centered ligand scaffold containing the
remaining functional groups and combining said bidentate
ligandscaffold with a catalytic metal Morderivative thereof
whereby the remaining functional groups combine to ligate
M, thereby forming said catalyst.
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2
of such structures has long been the goal of the research in this
area, but to date, the preparation of functional structures is
still rather rare Yoshizawa, M.; Takeyama, Y.; Kusukawa, T.;
Fujita, M. “Cavity-directed, highly stereoselective 2+2 pho

SELF-ASSEMBLED HETEROLEPTC

CHIRAL LIGANDS,ASYMMETRIC
CATALYST SYSTEMIS AND METHODS

todimerization of olefins within self-assembled coordination

CROSS-REFERENCE TO RELATED
APPLICATIONS

This application claims the benefit of priority of Provi
sional Application Ser. No. 60/638,760 filed Dec. 23, 2004.
This invention was made with Government support under
N00014-05-1-0527 awarded by the Navy/ONR and under
GM070939 awarded by the National Institute of Health. The
Government has certain rights in the invention.
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J. Chem. 2003, 27, 68-72; Braunstein, P.; Clerc, G.; Morise,

FIELD OF THE INVENTION

The invention relates to novel catalysts and catalysis reac
tions employing same.
BACKGROUND OF THE INVENTION

Catalysis and asymmetric catalysis are processes of com
mercial importance in synthetic chemistry. The development

25

of efficient methods to enable the reliable, stereocontrolled

synthesis of Small molecule target structures is an important
goal relevant to the synthesis of compounds of commercial
interest Such as pharmaceutical drugs, agrochemicals and
compounds with interesting materials properties. Asymmet
ric catalysis plays an important role in meeting this goal, and
while tremendous advances have been realized in this rapidly
moving field of research, significant problems remain.
Among the most important of these problems are the need for
(i) better substrate generality and/or more precisely substrate
tunable catalyst systems, (ii) better catalyst stability (i.e.,
higher turnover number, TON), and (iii) better catalyst effi
ciency (i.e., higher turnover frequency, TOF). Solutions to
these problems hinge on discovering and optimizing new
ligands and catalyst Systems, and understanding the reasons
for their effectiveness. Most modular approaches start with
one or a Small set of scaffolds (equivalently, backbones or
templates) and sequentially append the plural ligating Sub
stituents. The idea is to systematically vary the nature of the
ligating groups (i.e., vary their elemental identity, shape,
steric demand, and electronic character) to tune or optimize
the asymmetric environment at the site of catalysis as well as
define the nature of the metal-ligand interaction.
An interesting scaffold is selected and one sequentially
couples a series of ligating Substituents in ligand diversifica
tion steps. The ligands are then evaluated in the reaction(s) of
interest. This linear synthetic approach employed with this
strategy has worked well; however, the necessity for prepar
ing as few as 20-25 chiral ligands using this approach greatly
reduces the efficiency thereof. Limitations such as these
demand new approaches to the problem.
For example, metal-directed self-assembly has been a very
active area of research over the past decade and as a result
facile routes to a wide variety of multiple metal containing
metallocycles and metallocages have been defined Holliday,
B. J.; Mirkin, C. A “Strategies for the construction of
Supramolecular compounds through coordination chemis
try.” Angew. Chem. Int. Ed. 2001, 40, 2022-2043; Leininger,
S.; Olenyuk, B.; Stang, P. J. “Self-Assembly of Discrete
Cyclic Nanostructures Mediated by Transition Metals.”
Chem. Rev. 2000, 100,853-907). The potential for novel uses

cages.” Angew. Chem. Int. Ed. 2002.41.1347-1349.
Recently, several reports have appeared wherein self-assem
bly is used to generate novel bidentate ligands Larsen, J.;
Rasmussen, B. S.; Hazell, R. G.; Skrydstrup, T. "Preparation
of a novel diphosphine-palladium macrocyclic complex pos
sessing a molecular recognition site. Oxidative addition stud
ies. Chem. Commun. (Cambridge) 2004, 202-203: Braun
stein, P.; Clerc. G.; Morise, X. “Cyclopropanation and Diels
Alder reactions catalyzed by the first heterobimetallic
complexes with bridging phosphinooxazoline ligands. New
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X. Welter, R.; Mantovani, G. “Phosphinooxazolines as
assembling ligands in heterometallic complexes. Dalton
Transactions 2003, 1601-1605; Breit, B.: Seiche, W. “Hydro
gen Bonding as a Construction Element for Bidentate Donor
Ligands in Homogeneous Catalysis: Regioselective Hydro
formylation of Terminal Alkenes.J. Am. Chem. Soc. 2003,
125,6608-6609; Siagt, V. F.; Van Leeuwen, P. W. N. M.; Reek,
J. N. H. "Bidentate Ligands Formed by Self Assembly.”
Chem. Commun. (Cambridge) 2003.2474-2475; Hua, J.; Un,
W. “Chiral Metallacyclophanes: Self-Assembly, Character
ization, and Application in Asymmetric Catalysis.” Org. Lett.
2004, 6, 861-864: Jiang, H.; Hu, A: Un, W. “A chiral metal
lacyclophane for asymmetric catalysis. Chem. Commun.
(Cambridge) 2003, 96-97; Lee, S.J.; Hu, A.; Un, W. “The
First Chiral Organometallic Triangle for Asymmetric Cataly
sis,” J. Am. Chem. Soc. 2002, 124,12948-12949 and catalyst
systems Gianneschi, N. C.; Bertin, P. A.; Nguyen, S. T.;
Mirkin, C. A. Zakharov, L. N.; Rheingold, AL. “A Supramo
lecular Approach to an Allosteric Catalyst.” J. Am. Chem. Soc.
2003, 125, 10508-10509; Mikami, K. Tereda, M.: Korenaga,
T.: Matsumoto.Y.; Ueki, M.; Angeluad, R. “Asymmetric acti
vation.” Angew. Chem. Int. Ed. 2000, 39, 3532-3556;
Mikami, K., Matsukawa, S.; Volk, T.: Terada, M. "Self-as
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sembly of several components into a highly enantioselective
Ti catalyst for carbonyl-ene reactions. Angew. Chem., Int.
Ed. Engl. 1998, 36, 2768-2771. The general approach
employed is outlined in FIG.1. A metal-containing (or mul
tiple metal-containing) scaffold is synthesized and combined
with two or more bifunctional subunits leading to formation
of the self-assembled ligand (SAL) 1. In general, the ligands
prepared via this approach are symmetric since the ligating
groups incorporated are identical; i.e., homoleptic complexes
(i.e., two identical ligating groups) are formed. Several
research-groups recently described Successful efforts to pre
pare chiral SALs for asymmetric catalysis via the above
described metal-directed self-assembly.
It is an object of the invention to provide novel asymmetric
catalysts prepared by a novel combinatorial method.
It is a further object to provide novel catalyst systems
containing the novel asymmetric catalysts.
It is a still further object of the invention to provide novel
catalysis methods employing the novel asymmetric catalysts
and catalyst systems of the invention.

60

SUMMARY OF THE INVENTION

The above and other objects are realized by the present
invention, one embodiment of which relates to a method of

65

synthesizing a heteroleptic, multiple metal-containing metal
locyclic catalyst, particularly Suited for asymmetric catalysis,
comprising combining a plurality of plural functional group

US 7,847,114 B2
3
containing, monodentate ligands of complementary chirality,
the plural functional groups being tethered to each other by
tethers in the presence of a scaffold-structural metal Ms or
derivative thereof, wherein at least one functional group on
each ligand combines to ligate M to form a bidentate, M.
centered ligand scaffold containing the remaining functional
groups and combining the bidentate ligand scaffold with a
catalytic metal M or derivative thereof whereby the remain
ing functional groups combine to ligate M, thereby forming
said catalyst.

5

10

A further embodiment of the invention concerns a method

of synthesizing a heteroleptic, multiple metal-containing
metallocyclic catalyst, particularly Suited for asymmetric
catalysis, comprising combining, in the presence of a scaf
fold-structural metal Ms or a derivative thereof, plural bi
functional group-containing, monodentate ligands of
complementary chirality having the formulae:

15

Additional embodiments of the invention comprise the
asymmetric catalysts formed by the above-described meth
ods.

Still further embodiments of the invention concern catalyst
systems comprising the above asymmetric catalysts Sup
ported on Suitable Substrates for use in catalysis methods.
More embodiments of the invention relate to chemical

catalysis methods employing the above described asymmet
ric catalysts and catalyst systems.

1.

LR

BRIEF DESCRIPTION OF THE DRAWINGS
25

FIGS. 1-4, 6-12 set forth reaction schemes for various of
the methods described herein.

and

FIGS. 5 and 16 set forth analytical data for various of the
compounds described herein.
30

L2

FIGS. 13-15 set forth Structural formulae for various of the

compounds described herein.
DETAILED DESCRIPTION OF THE INVENTION

2

LS

2N

T2

35

40

7

define a chiral surface and the electronic nature of the metal

45

wherein: the LS are ligating functional groups of comple
mentary chiralty capable of ligating a scaffold-structural
metal M, the LS are ligating functional groups capable
of ligating a catalytic metal M
and T are tethers
linking said LS to said LS, to form a bidentate, M
centered ligand Scaffold having the formula:

-SMs.
LR
L2

50

55

1 'N LS

The present invention is predicated on the discovery of a
method ofusing metal-directed multi-component self-assem
bly in a new combinatorial approach to the design and opti
mization of ligands and catalyst systems. The modular biden
tate ligand design of the invention is based on the Scientific
hypothesis that the nature of the ligating group can be used to

, and

L2

combining the bidentate ligandscaffold with a catalytic metal
M or derivative thereof whereby the remaining functional
groups, L combine to ligate M, thereby forming the catalyst
having the formula:

60
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ligand interaction, and that, then, the ligand scaffold can be
varied through combinatorial synthesis to define the optimal
orientation of that chiral Surface (ligating group) for efficient
asymmetric catalysis.
Ultimately, the goal of all chiral ligand designs is to (i)
create an appropriate "chiral pocket around the metal to
direct stereochemistry, and (ii) impart the appropriate elec
tronic characteristics at the metal centerfor efficient catalysis.
The present invention achieves these goals utilizing a conver
gent approach to ligand Scaffold optimization using metal
directed multi-component self-assembly. Multi-component
reactions have garnered much attention as Synthetic strategies
due to their potential to increase diversity while simplifying
the synthesis of structurally complex compounds. Multi
component self-assembly offers the same potential benefits in
ligand synthesis of the present invention.
The method of the invention comprises three basic steps
(FIG. 2). One of the novel aspects of the invention resides in
the fact that the ligandscaffold is established in the last step of
the synthesis. The first two steps parallel that of the typical
modular approach, except that they are applied to separate
halves of the ultimate bidentate ligand: (i) selecting the series
of tether subunits begins to define the scaffold and (ii) select
ing the series of ligating groups begins to define both the
nature of the metalligand interaction and the topology around
the catalytic metal. The third step, the convergent self-assem

US 7,847,114 B2
5
bly, connects bifunctional ligands to fully establish both the
scaffold as well as the precise combination of ligating groups
in self-assembled ligand (SAL) 9. The inventive method is
based upon forming a heteroleptic metal complex and can be
carried out in a combinatorial fashion. Self-assembly leaves a
second set of ligating groups now suitably disposed to bind a
second metal. Addition of that catalytic metal (Me) completes
the bimetallic catalyst 10. Other modular ligand designs
attach ligating groups as Substituents to a preformed scaffold.
Here, metal-directed self-assembly generates the scaffold as
the final step, and as such, allows the rapid assembly of a
diverse set of scaffolds and more thoroughly optimize its

6
ladium-catalyzed asymmetric allylic alkylation and amina
tions; palladium-, rhodium-, and iridium-catalyzed asymmet
ric enyne cycloisomerizations; palladium-, rhodium-, and
iridium-catalyzed asymmetric cyclizations and cycloisomer
izations; rhodium-catalyzed alkene hydroformylation; and
the like.

10

Structure.

The heteroleptic self-assembly approach of the invention is
fundamentally different from the modular approach of the
prior art and provides a powerful approach to the construction
of novelligand libraries. The design concept of the invention
is illustrated in more detail in FIG.3. To execute the approach,
a simple, efficient, and mild method was designed for the
metal-directed heteroleptic self-assembly via the selective
Zinc(II)-complexation of bisoxazoline (box) subunits of
complementary chirality. The box-tethered chiral monoden
tate ligands 11 were used as the bifunctional ligands. Two
independent bifunctional ligands bearing box subunits of
opposite chirality self-assemble upon treatment with
Zn(OAc) to give a neutral complex, a chiral bidentate SAL
12. Each independent half in this convergent route is in turn
prepared from three modules, (i) an (R) or (S)-box subunit;
(ii) a tether subunit; and (iii) a ligating group. As exemplified
below, the latteris introduced in the penultimate or a late stage
step of the synthesis, with combinatorial zinc-directed self
assembly as the final step. Thus, there exists the capacity for
extensive diversification in the last two steps of the synthesis
with self-assembly establishing both the final structure of the
ligand scaffold and the exact combination of ligating groups
in a SAL library. Structure 14 (discussed in detail below)
illustrates how the concept of the invention is reduced to
practice.
It is known that metalloenzymes often use two types of
metals to carry out their function.
Structural metals help generate the three-dimensional
structure, and a second metal binding site is often part of that
structure. An independent, catalytic metal binds to this latter
site to carry out the required chemistry. The system of the
invention mimics that strategy. A neutral, heteroleptic (box)
Zn complex, wherein the Zinc serves as a structural metal. At
the same time, the process of self-assembly constructs a chiral
binding site for a second, independent metal to bind and effect
catalysis.
Any suitable metal or combination of metals may be
employed in the practice of the invention, including, for
example, Zn, Co., Rh, Mg, Ca, Ba, Ti, Zr, and the like.
Also, any suitable ligating group may be employed in the
practice of the invention, including but not limited to those
exemplified herein. Suitable tethering groups also include,
but are not limited to, those exemplified below. Preferred
tethers are alkyl (e.g., Substituted alkane and cycloalkane)
and aryl (e.g., Substituted phenyl and biphenyl) groups.
The self-assembled chiral catalysts and catalyst systems of
the invention may be employed in any chemical process cata
lyzed by any ligated metal catalyst, including, but not limited
to, those exemplified herein as well as rhodium- and iridium
catalyzed asymmetric hydrogenation of alkenes; rhodium-,
iridium-, and ruthenium-catalyzed transfer hydrogenation of
alkenes, carbonyls and imines; rhodium-, iridium-, and ruthe
nium-catalyzed dehydrogenation of alcohols; rhodium- and
iridium-catalyzed asymmetric hydroboration of alkenes; pal

15

25

30

35

The need to carry out efficientenantioselective catalysis is
frequently encountered, for example, in chemical discovery
and process research (such as commonly encountered in the
synthesis of pharmacuticals and pharmaceutical intermedi
ates), and for each particular Substrate, the typical approach is
to screen a series of chiral ligands looking for the most Suit
able catalyst system. The present invention, embodying the
use of SALS introduces a new paradigm for chiral catalyst
development, develops a niche for custom asymmetric cata
lysts, for example, for asymmetric allylic amination, asym
metric hydrogenation, and asymmetric hydroboration. More
over, the chiral ligand libraries (exemplified below) produced
also find applications in numerous other metal-catalyzed
reactions, provided, of course, that the reactions do not
require the use of reagents that have deleterious effects on the
catalysts.
Those skilled in the art will realize that the SAL concept
described herein may be extended from one that focuses
exclusively on the design of chiral bidentate ligands to
include polydentate ligands, for example, tri- or tetradentate
ligands. One box derivative will contribute abidentate ligand
upon self-assembly, the other a mono- orbidentate ligand as
needed, for example, the development of polydentate chiral
SALs, particularly for expanding the chiral ligand systems for
lanthanide catalysis. The invention is also applicable for
developing bifunctional catalysts systems, reversible reagent
delivery, and sequenced multi-component reactions; indeed,
virtually any combinatorial chemical synthesis.
EXAMPLE 1.

40

45

50
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Referring to FIG.4, the neutral, homochiral complex (R.R17) is formed by stirring two equivalents of (4R,4R)-15 with
Zn(OAc). Zn(OAc) serves a dual role in the reaction, simul
taneously delivering the metal center and the required base.
However, when a racemic mixture of box ligands (i.e., one
equivalent each of (4S.4'S)-15 and (4R,4'R)-15) is combined
with Zn(OAc), three complexes could theoretically form, the
homochiral complexes (S,S)—and (R,R)-17 (i.e., chiral self
recognition) and the heterochiral complex (S,R)-16 (i.e.,
chiral self-discrimination). The tetrahedral coordination
geometry of Zinc(II) strongly favors self-discrimination in
this case. Indeed, only the neutral, heterochiral complex
(S,R)-16 is observed.
EXAMPLE 2

FIG. 5 compares the 1H NMR spectrum for the free box
ligand 15 (tracea) to those of the heterochiral ((S,R)-16, trace
b) and homochiral complexes ((R,R)-17, trace c). These spec
tra show that the homochiral and heterochiral complexes are
distinctly different in solution, and to the level of NMR detec
tion, the combination of (4S.4'S)-15 and (4R,4'R)-15 with
Zn(OAc) affords exclusively the heterochiral complex. Of
particular note in the spectrum of (S,R)-16 is the dramatic
upfield shift for the hydrogen on the phenyl-bearing carbon of
the dihydrooxazole ring (H"; see structure 15, FIG. 4). It is

US 7,847,114 B2
7
highly shielded in the heterochiral complex relative to the free
ligand or homochiral complex.

8
CDOD to a solution of (S,R)-16 (CDCI) shows complete
H/D exchange by the time the 1H NMR spectrum is recorded.

EXAMPLE 3

EXAMPLE 6

To better understand the factors favoring self-discrimina
tion over self-recognition, crystals of (S,R)-16 and (S,S)-17
were grown and their structures determined by X-ray analysis
(FIG. 6). The heterochiral complex (S,R)-16 exhibits near
perfect tetrahedral coordination while the homochiral com
plex (S,S)-17, for which there are two closely related con

The facile formation of a heterochiral complex is not lim
ited to zinc. The corresponding heterochiral Co(II) complex
was prepared. Its crystal structure is virtually Superimposable
on that of the zinc structure.
10

EXAMPLE 7

formers in the unit cell, distorts from tetrahedral coordination

to minimize steric interactions between the phenyl substitu
ents of the two box ligands. Otherwise, the bond lengths and
angles vary little between the two complexes. The crystal
structures are consistent with the NMR data, particularly the
positioning of the phenyl groups in the heterochiral complex
(S,R)-16 so as to shield the hydrogen on the phenyl-bearing
carbon of the dihydrooxazole ring (H).

15

EXAMPLE 8

EXAMPLE 4

Heterochiral complexes such as (S,R)-16 are meso by
inversion symmetry and hence achiral. Nevertheless, the pro
cess of chiral self-discrimination is inherently one of hetero
leptic self-assembly (i.e., non-identical groups bond to the
metal) and is not restricted to combining pairs ofenantiomers.
Pseudo-enantiomers can combine similarly to afford prod
ucts lacking a center of inversion. To illustrate this and the
potential versatility for preparing chiral, heteroleptic com
plexes, the pseudo-racemic combination (4S.4'S)-18 and (4R,
4R)-19 was used to prepare the mixed cyano/benzyl-substi
tuted complex 20 (FIG. 7). In spite of the complementary
chirality of the box moieties, complex 20 lacks inversion
symmetry and is chiral, exhibiting a large optical rotation,
C-203° (c=0.75, CHCl).

Self-assembly is also not limited to methylene box sub
strates or to the 4-phenyl-substituted box ligands illustrated.
Corresponding complexes from 4.5-diphenyl and indanyl
box derivatives have been prepared as well; for example, the
crystal structure of the heterochiral (indanylbox)Zn complex
21 is shown above (FIG. 7).

25

It was found that the heterochiral (box)Zn complex, once
formed, is stable toward exchange with several common
ligands (e.g., 2.2-isopropylidenebis(4-phenyl-2-oxazline),
PhP BINAP, BINOL and diethyl tartrate). Furthermore, sev
eral potential ligands (i.e., 2,2'-isopropylidenebis(4-phenyl
2-oxazline), PhP CY3P. dppe) were tested in direct compe
tition and do not to interfere with formation of the

30
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heterochiral complex. Their chemical characteristics, the
structural Studies, and their self-sorting and stability tests
gave confidence that neutral, heterochiral (box)Zn com
plexes would remain intact and could be used in the presence
of other Suitable ligands. Their preparation is simple: mix the
two enantiomeric box derivatives with Zn(OAch, remove the
solvent (CH.Cl/MeOH), triturate with methanol, and wash
the resulting solid with methanol. The synthetic yields are
high (typically 70-90%), and examination of the crude prod
uct reveals no side products. Mechanical losses probably
account for the less than perfect isolated yields obtained.

40

EXAMPLE 9
EXAMPLE 5

The neutral Zinc complexes prove to be quite remarkable
compounds. Complexation is reversible in the presence of a
proton Source, for example, adding another (R)- or (S)-box
derivative leads to rapid substitution, and mixing equal
amounts of the enantiomeric homochiral complexes 17 leads
to their rapid disproportionation (FIG. 6). Complete conver
sion to the heterochiral complex (R.S)-16 as judged by 1H
NMR again indicates that the heterochiral complex is the
thermodynamic sink. The neutral metal complexes are typi
cally freely soluble in a variety of organic solvents (e.g.,
toluene, CHC1, CHCl, THF, dioxane, and acetonitrile) and
partially soluble in methanol. They are generally insoluble in
hexanes, diethyl ether or cold methanol, and these latter
organic solvents can be used to precipitate the complex from
other solvents and/or wash the precipitated complex. It was
Surprising to find that, in some cases, the complexescan be
subjected to column chromatography on silica (1% MeOH in
CHCl eluent) with little or no loss of zinc. Complex 16 is
insoluble, but stable toward water, and can be subjected to
extractive workup. Drying the organic phase with anhydrous
Na2SO does not affect metal exchange. The complex is not
completely inert toward protic solvents. For example, adding

45

50

55

60

To get a better idea of the tether structure that would be
needed to realize the approach in FIGS. 7 and 8 the hetero
chiral (benzylBox)Zncomplex 22 (FIG. 8) was prepared and
crystallized. By analysis of its crystal structure, and from
manipulating that structure in Chem3D, it is apparent that the
appended benzyl groups are of Sufficient length to extend
beyond the bulk of the (boxh)2Zn core, i.e., the benzyl groups
can freely rotate and extend beyond the metal complex core.
In fact, the core is quite compact; its end-to-end length is a
little shorter than that of biphenyl. It was reasoned that sub
stituted benzyl or biphenyl tethers should extend a tethered
ligating group beyond the core and permit chelation as
depicted schematically in FIGS. 7 and 8. The complex is also
inherently a rather rigid structural element, contrary to what
might be predicted. There is only one rotational degree of
freedom relating the positions of the two benzyl substituents
(i.e., would be tethers), two independent rotatable bonds but
since they lie along the same axis it introduces a just single
rotational degree of freedom.
EXAMPLE 10

65

In light of the crystal structure of 22 and with an eye toward
keeping the tether subunits relatively rigid, a series of substi
tuted benzyl and biphenyl tethers was focused on for prepar

US 7,847,114 B2
ing SALS (FIG. 9). The synthetic route is illustrated for the
preparation of 24F.The key step is mono-alkylation of the box
subunit with a substituted benzyl bromide bearing a pendant
silyl-protected hydroxyl substituent. For these initial studies,
the derivative was prepared bearing a pendant TADDOL
derived monophosphite. Deprotection of the silyl ether fol
lowed by coupling with (R,R)-TADDOL)PCI affords the
desired bifunctional box-(TADDOL)phosphite conjugate
24F. The six step synthesis is quite efficient, and, typically
5-10 mmol of the penultimate intermediate, the alcohol 23, is
prepared.

10
teristics of the ligating groups are constant in this ligand
library; only the ligand scaffold is varied. The idea was to
determine whether the structure of the scaffold alone is suf

10

EXAMPLE 11
15

Treating the combination of (S,S)-24F and (R,R)-24F with
Zn(Oac) affords the pseudo-C2-symmetric complex 25FF
(FIG. 10). The reaction is carried out by mixing the two
diastereomeric bifunctional ligands (24F) with Zn(Oac),
removing the solvent (CH2Cl2/MeOH), triturating with
methanol, and washing the resulting Solid with methanol. The
following data Support its structural assignment. (1) The two
diastereomeric bifunctional ligands (24F) are freely soluble
in methanol, 25FF is not; the recovery of 25FF is high (79%).
(2) The optical rotation of 25FF is lower than either of the 24F
diastereomers. (3) 25FF melts with decomposition at a tem
perature 25-30 degrees higher than the melting points of the
24F diastereomers. (4) The HRMS matches for the parention
of 25FF: the experimental and simulated isotope distribution
patterns match. (5) The I H and 13C NMR spectra are con
sistent with an overall pseudo-C-symmetric structure and
show the expected elements in common 22, the dibenzyl box
model compound for which the crystal structure is known. (6)
The 31p NMR spectrum of 25FF shows a single resonance at
130.2 ppm, similar to that of its precursor (S,S)-24F (130.7
ppm).

it can be seen that the enantiomeric excess varies almost
25
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Having formed 25FF, the crucial question is whether the
pendant phosphites can coordinate a second metal. To test
this, 25FF was treated with an equivalent of (cod), RhBF.

The 'P NMR signal at 130.2 ppm, characteristic of a free

45

(J-248.6 Hz). The results are consistent with the forma

tion of the chiral heterobimetallic rhodium complex (cod)Rh
(25FF)|BF (26). Demonstrating that SAL 25FF forms a
rhodium(I) complex is of particular relevance to, for example,
(SAL)RhX-catalyzed asymmetric hydroboration reactions.

50

EXAMPLE 13

The selective formation of the heteroleptic (box)Zn com
plex is driven by the complementary chirality of the box
subunits and is essentially independent of the nature of the
remote substituents on each box ligand. A series of bifunc
tional ligands 24A-M were prepared (FIG. 11). For the pur
poses of this initial study the ligating group was kept constant,
the choice of the TADDOL-derived monophosphite ligating
group was more or less arbitrary. Treating complementary
combinations of bifunctionalligands 24A-M with Zn(OAch
is a simple way to prepare a library of SALs 25XY. We
prepared 50 of the 169 possible combinations of subunits
24A-M. Each SAL 25XY bears two pendant TADDOL-de
rived monophosphites, thus the shape and electronic charac

linearly over a wide range (i.e., 20-97% ee). Two thirds of the
SALS screened give a higher level of asymmetric induction
than the monomer (R,R)-TADDOL)POPh. While the goal,
of course, is to obtain enantiomerically pure material directly
from the reaction, products obtained at the level of 90% ee
(95:5 er) are often practical; they can often be enriched to
enantiomeric purity via one recrystallization with minimal
losses. Nine combinations of SAL 25XY effect the asymmet
ricallylation in 90% ee or higher.
The variation in enantiomeric excess demonstrates the

EXAMPLE 12

phosphite, is lost and a new doublet appears at 112.7 ppm

ficient to control the level of asymmetric induction exhibited
by the derived catalyst systems. The SALs were screened in
the palladium-catalyzed asymmetric allylic amination of
racemic carbonate 27 by N-methyl-p-toluenesulfonamide.
Chiral diphosphites have been employed in a wide range of
asymmetric reactions, including palladium-catalyzed allyla
tions; the latter are frequently used as a testing ground for new
chiral ligand motifs. For reference, the corresponding allylic
amination using two equivalents of ((R,R)-TADDOL)POPh
(29, i.e., the same chiral ligating group without the SAL)
gives (R)-28 (R-Me) in 48% ee.
The chiral diphosphites screened differ only in the struc
ture of the self-assembled ligand scaffold, and while each
gives predominantly (R)-28 (R-Me), the variation in enanti
oselectivity is striking. Plotting the results obtained for the 50
combinations of subunits A-Min descending order (FIG. 11),

55
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ability to use very Subtle changes in the scaffold to manipulate
the ligand topography around palladium. As tabulated in
Table 1 each of the top catalysts contains one of two closely
related subunits, F or H. These two tethers differ only in
regard to the Substitution pattern (1.3- VS. 1.4-) on the phenyl
ring closest to the box subunit. The most Successful ligand,
25FH, contains both subunits and affords 28 (R-Me) in 97%
ee (entry 1). Surprisingly, the pseudo-C2-symmetric deriva
tives 25FF and 25HHare less effective, giving 84% and 87%
ee respectively (entries 11 and 12). Compared to the latter
two, the combinations 25FG and 25GH (entries 8 and 10;
90% and 87% ee) are similar to, perhaps slightly superior, and
yet, 25GG is one of the worst combinations (entry 50.20%
ee). The presence of For H in and of itself does not guarantee
success; 25AF is another of the worst combinations (entry 49,
20% ee). It is interesting to see that two poor subunits can
form a favorable combination. Neither 25AA (60% ee) nor
25KK (31% ee) are very good, but the combination 24AK at
75% ee is the best SAL lacking eitheran For H subunit. When
the substrate is changed, even modestly, SAL 25FH is no
longer always the best choice. This highlights another feature
of the self-assembly approach of the invention: easy ligand
tunability. Chiral diphosphites 25FF, 25FH, and 25HH were
screened with four other N-substituted sulfonamides giving
the allylation product in high enantiomeric excess, for
example (results for best SAL shown), N-(n-butyl) (25FF,
90% ee), -benzyl (25FH, 91% ee), -isopropyl (25HH, 95%
ee), and -phenyl (25FF, 88% ee).

US 7,847,114 B2
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TABLE 1.

TABLE 1-continued

Data Summary Table 1. Screening SALS 25XY in the palladium
catalyzed allylic amination reaction with TsN(H)Me.

Data Summary Table 1. Screening SALS 25XY in the palladium
catalyzed allylic amination reaction with TsN(H)Me.
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2O
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28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50

FJ
H
EH
FL
HL
GH
HM
FG
HH
EF
FI
HK
FK
AK
AH
M
CF
K
CH
E
AA
CC
CK
G
M
MM
J
AC
C
K
L
A.
G
C
E
BB
L
J
EE
AJ
KK
DD
AF
GG

93
93
92
92
92
90
90
87
87
84
8O
8O
78
77
75
75
75
72
71
67
67
63
62
60
60
55
S4
S4
S4
51
50
47
47
46
44
44
43
42
40
40
40
37
34
33
31
23
2O
2O

EXAMPLE 1.4

Studies on the hydroboration of styrene were carried out
using a screening set of SALS. Two simple tethers were cho
sen, one phenol and one benzyl amine. Prepared derivatives
A-Hare illustrated in FIG. 12. Combinations of A-Husing the
Zn(Oac) protocol afford a small screening set of SALS
50XY. Some preliminary data obtained with them are sum
marized in Table 2. Since the scaffold is not optimized at this
stage, it was not expected to obtain the highest possible enan
tiomeric excess. However, useful information can be obtained

from the relative activity of the catalysts from the various
combinations, and in the case of styrene, the regioselectivity
(i.e., branched versus linear alcohol). To get a rough measure
catalyst activity, each reaction was run for the same standard
time; consequently, the observed yield is a measure of cata
lyst turnover frequency and/or number.

US 7,847,114 B2
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in the rhodium-catalyzed hydrogenation of the amino acid
precursor, enamide 7. The monomeric ligands shown corre
spond to ligating groups that could readily be incorporated in
the SAL precursors described above.

13
TABLE 2

(50XY)Rh(cod)Cl]-catalyzed hydroboration of styrene.
The product is predominantly R.

5

Entry

5OXY

Yield (%)

51:52

ee (%)

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18

AA
AB
AC
AD
AE
AH
BB
BD
BF
BG
CF
CG
CH
DD
E
F
GG
G

98
88
90
90
30
95
75
85
95
99
8O
90
90
26
50
35
41
90

2.5:
1.S:
6.1:
4.3:
1:1.3
6.6:
1:
2:
4:
2:
10:
15:
6.9:
1:1.
1:2.5
1:1-2
1:1.
1:3

76
2
46
60
3
78
O
17
7
14
8
7
4
3
4
30
3
10

The results in Table 2 are very encouraging. They demon
strate that one can Successfully use SALS in this reaction, and
as expected, the various combinations 50XY show a wide
range of behavior: yields vary from no reaction (50H1, data
not shown) to near quantitative (50BG, entry 10); regioselec
tivity varies from 15:1 favoring the branched alcohol (50CG,
entry 12) to 1:3 favoring the achiral linear isomer (50GI, entry
18); and the enantioselectivity reaches as high as 78%. This

TABLE 3
O

1% Rh(coo)2BF4
1.1% total Egand
CH2Cl2, 25 psi H2,

OMe

NHAC

10 h, rt

7
15

O
OMe
NHAC
8

(S)-IV
25 In

In
III,
30 (S)-IV,

means that the elements in the SAL which can be varied are

(R)-V

very much involved in determining reaction selectivity. For
example, it is particularly striking how strongly the presence
of subunit C improves the regioselectivity toward the desired
branched isomer.

N

10

VI,
35

VII,

(R)-V,

VI,

VII,

The need to carry out enantioselective hydrogenation is
frequently encountered in chemical discovery and process
research. Such processes are relevant to the production of a
wide range of synthetic intermediates andare of Substantial
industrial importance. There exist significant drawbacks to
carrying out these types of reactions utilizing currently avail
able catalyst systems. The reaction also constitutes a common
testing ground for new ligand systems for asymmetric cataly
sis. Having used palladium-catalyzed allylic amination to
demonstrate proof of principle for the method of the invention
above, asymmetric hydrogenation offers the opportunity to
evaluate the approach with a different metal and in very

5
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10

100

10

1

(1 S)

(5 S)

(7 R)

(5 R)

(2S)

(5 S)

93

99

26

100

100

90

99

(rac)

(1S)

(3S)

(1S)

(5S)

(1 R)

(7 S)

1OO

89

68

94

55

100

100

(rac)

(rac)

(8R)

(3R)

(12 S)

17

7

3

18

98

(10 R)

(1 S)

(8 S)

(33 R)

(8R)

2O

42

16

97

(26R)

(43 R)

(29 R)

(rac)

5

14

24

(4 S)

(6 S)

(2R)

24

100

(34R)

(4R)

(1S) (13 S)
15

42

(3 S) (57 S)
14

37

(3S) (61 S)
3

19

(10 R) (43 S)
19

98

(4 S) (57 S)

100

1OO

1OO

(11 R)

(4R)

(rac)

1OO

1OO

(2S) (76S)
(R)-X.

1OO

(65 S)

40

"The table entries refer the combination of ligands (0.55 mole percent of each) used for that
reaction; the chemical yields are shown along with the 96 ee's obtained and the major
enantiomer formed given in parentheses, For example, data in the first row show the results
obtained using the combination of 0.55 mole percent of ligand I with 0.55 mole percent of
each of the chiral monomeric ligandsV. through *X,
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different reaction.

A new concept in asymmetric catalysis has previously been
reported, i.e., the idea of screening combinatorial mixtures of
simple monodentate ligands. In rhodium-catalyzed hydroge
nation reactions, prior researchers found that the enantio
meric excess obtained from certain mixtures of ligands was
higher than that obtained with either ligand alone.
In the SAL approach of the present invention, there exists
considerable flexibility as to the choice of ligating groups.
Thus, it is desirable to select the combination(s) of ligating
groups that will most likely afford efficient catalysts (effi
ciency as defined by yield and reaction rate as well as selec
tivity), and then rely on the ability to vary the SAL scaffold to
optimize their orientation and hence the enantioselectivity. To
aid in selecting the most promising ligating group(s) for pre
paring the SAL library, various combinations of the mono
meric modelligands (I-X) shown in FIG. 14 were screened

(R)-X.

5

IX.

Rhodium-Catalyzed Asymmetric Hydrogenation

IX

(5S)

VIII,

EXAMPLE 1.5

VIII,

55

The tabulated screening data (Table 3) provide a great deal
of information. The goal of the study is not to necessarily
identify the optimal monodentate ligand for the reaction;
others have successfully pursued that approach as described
above. Rather, the purpose is to identify promising ligating
groups that can readily be incorporated into SAL precursors
to prepare SAL libraries with which the potential for ligand
tuning via scaffold optimization can be evaluated. The vari
ous combinations of ligands I-X, give rise to wide varia
tions in yield and enantioselectivity in the rhodium-catalyzed
asymmetric hydrogenation of enamide 7. The axially chiral

BIPHEP phosphite derivative X, stands out as the most

interesting ligandscreened. Almost every combination with it
gives an appreciable level of enantioselectivity. Its hetero

combination with the TADDOLderivative “IX, is particu

60

65

larly intriguing. Considering the data in Table 1, the BIPHEP
phosphite ligating group appears to be the obvious lead struc
ture for an initial SAL library.
Investigating a combinatorial library of (R)BIPHEP-SALs
involved the preparation and screening of a library of 110
SAL combinations (i.e., SAL-9XY) in the rhodium-catalyzed
hydrogenation of the amino acid precursor, enamide 7. The
SALs screened were drawn from the set of subunits illustrated

in FIG.15 (i.e., SAL subunits A-L). Each subunit contains the

US 7,847,114 B2
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BIPHEP phosphite ligating group, and for the most part, the
SALs used in the (SAL9XY)Rh(BF)-catalyzed asymmet
ric hydrogenations of enamide 7 were prepared in situ by
combining the desired two SAL subunits with EtZn.
FIG. 16 shows the variation in enantioselectivity obtained
as a function of the SAL scaffold for the 110 SAL-9XY (X
and Y independently selected from among A through L) com
binations screened in the present study; the percent ee

5

16
topography defined by the BIPHEP phosphite moiety in the
chiral rhodium catalyst. The results suggest that a more
diverse set of SAL subunits is needed to further optimize the
scaffold structure or that the limit of the capacity to produc
tively orient the BIPHEP phosphite moiety has been reached.
Nonetheless, the best SAL combinations identified thus far
are already very close to giving useful levels of asymmetric
induction.
TABLE 4

(SAL-9XY)Rh(BF)-Catalyzed asymmetric hydrogenation of
dehydroaminoacid derivative 7 using
various combinations of BIPHEP-SAL subunils A-L.
O

1% Rh(coo)2BF4
N

OMe

NHAC

1.1% SAL-9XY

CH2Cl2, 25 psi H2, rt

7
O
OMe
NHAC
8
SAL
9XY
S-A

R-A

R-B

49

66

(62) (79)
S-B

SO

(69)
S-C

S

69

4

18
1

(34) (35)
S-E

6

(41)
S-F

13

(64)
S-G

10

S-I.

13

11
55
S4

55

60

65

78

3S

78

7

61

3

52

46

2

51

4

24

7

81

10

28

2

66

1

73

10

60

14

S9

38

96
92
38

R-L

100

49

23

75

(72) (73) (71) (69)
97

47

35

33

46

49

(76)

(72)

24 17

(43) (76) (75) (73)
17

71

54

35

(35) (79) (79) (75)

43

(75) (22) (73) (69) (65)

9

87

23
42

47
92

(67) (81) (45) (82)
11

35

6

31

27

90

70

(82)

(80)

25

45

(50) (76) (76) (78)
100

44

66

(55)

(66)

82

96

S8

28,

61

34

(28) (71) (16) (76)
97

30

93

(66) (78) (67) (80)
1

R-J

3

(76) (77) (73) (81)
44

R-I

(9)

(58) (80) (69) (78)

96
95

79

(13) (79) (35) (80)

21
28

26

R-H

(64) (78) (81) (78)

(58) (78) (58) (79)

(60) (17) (74)

(52) (70)

obtained is plotted from low to high. For reference, using two
equivalents of chiral monophosphite (BIPHEP)POPh (X)
gives 65% ee in the reaction. Once again, wide variation
exists in enantioselectivity, from racemic to above 80% ee.
with roughly two thirds of the SAL-9XY combinations
affording a higher level of asymmetric induction than the
model monomer X. The results of the screening reactions
reflect only the influence of varying the scaffold structure;
every SAL in the screen has the same set of BIPHEP ligating
groups. The graph is qualitatively similar to that seen for the
palladium-catalyzed asymmetric allylic amination reported
above; however, unlike that study, here, the plot levels off.
Apparently, many of the variations in Scaffold are effec
tively redundant; that is, they do not significantly alter the
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(61) (73) (59) (75)

(31)

(65) (75)
S-K

R-F

(72) (59) (82)

(53) (76)
S-J

R-E

(66) (rac) (70)

(62) (73)
S-H

R-D

(76) (58) (75)

(57) (70)
S-D

R-C

1

89

(22) (78) (39) (82)

18
94

97

(54) (79) (76) (76)
98

67

S7

37

(52) (76) (78) (76)
10

68

13

26

(20) (79) (75) (75)

The detailed results of the screening reactions are Summa
rized in Table 4. Again, the data demonstrate wide variation in
both yield and enantioselectivity for the (SAL-9XY)Rh
(BF) catalyzed asymmetric hydrogenation. While the latter
ranges from racemic to above 80% ee, the
S-enantiomer predominates in all non-racemic products
obtained. Eleven combinations (i.e., those highlighted in
boldface in Table 4) give 80% ee or greater. An interesting
trend emerges from the data obtained with this combinatorial
library of 110 SALs. Nine of the eleven most successful
combinations contain subunit F., for example, the combina
tion using two F subunits, SAL-9FF, is among the best,
affording 81% ee (87% yield).
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However, small changes in the SAL scaffold can result in
large differences in enantioselectivity and yield. For example,
contrast the results obtained using SAL-9FF (81% ee, 87%
yield) to those obtained using the closely related structure
SAL-9EE (9% ee.3% yield). While each of the SALs in Table
4 is structurally unique, Some differ only very Subtly in Scaf
fold structure. For example, SAL-9FI can be prepared by
combining (S)-F with (R)—I or by combining (R)- F with
(S)-1. The resulting diastereomeric SALS generally behave
similarly, 82% ee (92% yield) and 81% ee (97% yield),
respectively, for the two combinations described.
The results obtained thus far make it clear that, while the
shape of the BIPHEP-phosphite ligating group within the
macro cyclic metal chelate is invariant, Small changes in the
ligand Scaffold reposition or reorient that shape to a more, or
less, effective position for asymmetric catalysis.
Suitable ligands and tethers are exemplified above; how
ever, it will be apparent to those skilled in the art that many
more such groups may be employed in the practice of the
invention and that the identification thereof would not require
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6. The catalyst of claim 1, wherein the ligating functional
groups are at least one of
Air

{

)

P

Air

(TADDOL)P15

O
CO
30

35

VP
/

(BINOL)P-

O

.

VP-.

40

wherein each of said L. and is capable of ligating said

45

wherein each of said L is capable of ligating said M.

wherein said T links each of said L. and is connected to

at least one of said L. and
wherein said T links each of said L and is connected to at
least one of said L.
2. The catalyst of claim 1, wherein the ligating functional
groups are (TADDOL)P (BINOL)P , or (BIPHEP)P
derivatives, said derivatives selected from the group of deriva
tives consisting of (TADDOL)P , (BINOL)P - or (BI
PHEP)P phosphites: (TADDOL)P (BINOL)P or (BI
PHEP)P - phosphoramidites:
and (TADDOL)P (BINOL)P or (BIPHEP)P phos
phinites.
3. The catalyst of claim 2, wherein the ligating functional
groups are (TADDOL)P (BIINOL)P or (BIPHEP)P
phosphites.
4. The catalyst of claim 2, wherein the ligating functional
groups are (TADDOL)P , (BINOL)P or (BIPHEP)P
phosphoramidites.
5. The catalyst of claim 2, wherein the ligating functional
groups are (TADDOL)P , (BINOL)P or (BIPHEP)P
phosphinites.

O s
Air
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M:

O

10

1. A heteroleptic, multiple metal-containing metallocyclic
catalyst having the formula:

wise configuration;
wherein said M is a scaffold-structural metal and wherein
the scaffold-structural metal is Zn(II) or Co(II):
wherein said M is a catalytic metal and wherein the cata
lytic metal is Rh(I), Pd(II) or Ir(I):
wherein each of said L is a ligating functional group;
wherein said T and T are each tethers;

O

X

the exercise of inventive faculties.
The invention claimed is:

wherein: L. and L. are each ligating functional groups of
complementary chirality, said L. having a counter
clockwise configuration and said L. having a clock

Air

50

55

60

65

7. The catalyst of claim 1, wherein the ligating functional
groups are selected from the group consisting of (TADDOL)
P , (BINOL)P , and (BIPHEP)P phosphites; and
wherein the catalytic metal is selected from the group con
sisting of Rh(I), Pd(II) and Ir(I).
8. The catalyst of claim 1 having the formula:

US 7,847,114 B2
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12. The catalyst of claim 1, wherein the tethers are:

10

L-X
11(X = O)

15

12(X = OCH2)

13. The catalyst of claim 7, wherein the scaffold-structural
metal is Zn(II) or Co(II).

13(X = O)
14(X = OCH2)

14. The catalyst of claim 1, wherein the catalytic metal is
Rh(I).
15. The catalyst of claim 1, wherein the catalytic metal is
35 Ir(I).
16. The catalyst of claim 1, wherein the catalytic metal is
Pd(II).

O

40

17. The catalyst of claim 1, wherein the scaffold-structural
metal is Zn(II).

L

1. X

15(X = O)
16(X = OCH2)

18. The catalyst of claim 1, wherein the scaffold-structural
45 metal is Co(Il).

